Focus on Beyond Rule of Five Molecules:
Targeting Hard-to-Drug Areas
As the significance of natural products, peptidomimetics, PROTACs, and other biologically relevant yet non-drug-like compounds continues to grow, CHEMriya broadens the molecular hunting grounds. It enables access to compounds designed for challenging drug targets, including those involved in protein-protein interactions, allosteric modulation, and emerging therapeutic areas.
The extended bRo5-focused collection offers compounds with enhanced molecular diversity, allowing for innovative solutions to previously undruggable targets.